Archives of Medical Research
Volume 35, Issue 6 , Pages 546-548, November 2004

Prevalence of factor V Leiden and G6PD 1311 silent mutations in dalmatian population

  • Vedrana Čikeš

      Affiliations

    • Laboratory for Molecular Biology, University of Split, School of Medicine, Split, Croatia
  • ,
  • Irina Abaza

      Affiliations

    • Laboratory for Molecular Biology, University of Split, School of Medicine, Split, Croatia
  • ,
  • Vjekoslav Krželj

      Affiliations

    • Department of Paediatrics
  • ,
  • Ivana Marinović Terzić

      Affiliations

    • Laboratory for Molecular Biology, University of Split, School of Medicine, Split, Croatia
  • ,
  • Robert Tafra

      Affiliations

    • Laboratory for Molecular Biology, University of Split, School of Medicine, Split, Croatia
  • ,
  • Anuška Trlaja

      Affiliations

    • Transfusion Medicine, University Hospital, Split, Croatia
  • ,
  • Eugenija Marušić

      Affiliations

    • Department of Paediatrics
  • ,
  • Janoš Terzić

      Affiliations

    • Laboratory for Molecular Biology, University of Split, School of Medicine, Split, Croatia
    • Corresponding Author InformationAddress reprint requests to: Janoš Terzić, Assistant Professor, University of Split, School of Medicine, Šoltanska 2, 21000 Split, Croatia. Tel. +385 21 557 944; Fax. +385 21 465 304

Received 26 March 2004; accepted 7 July 2004.

(04/068)

Background

Factor V Leiden has been described as a common genetic risk factor for venous thromboembolism. The geographic distribution of this abnormality varies greatly, being high in Europe and almost absent in Asia and Africa. Particularly high prevalence is observed in some Mediterranean countries, which suggests the Mediterranean origin of this mutation. Similarly, prevalence of silent mutation 1311 of the G6PD gene seems to be higher among Mediterranean populations. Since the Dalmatian population (of south Croatia) geographically belongs to the Mediterranean populations we analyzed the prevalence of FV-Leiden and silent mutation 1311 in this region. Furthermore, because the coincidence of G6PD deficiency and venous thromboembolism was described earlier, we tested a possible association of FV-Leiden and G6PD deficiency.

Methods

One hundred sixty-eight healthy blood donors and 55 G6PD deficient individuals originating from the Dalmatian region were tested for the presence of FV-Leiden mutation and silent mutation 1311.

Results

Prevalence of FV-Leiden among blood donors was 2.4%, while among G6PD deficient individuals it was significantly higher, 11% (p=0.011). Prevalence of silent mutation 1311 among blood donors and G6PD deficient individuals was 21 and 15%, respectively.

Conclusions

Observed allele frequencies among individuals originating from the Dalmatian region is similar to the neighboring European and Mediterranean populations. Interestingly, our results indicate the association of the FV-Leiden and G6PD deficiency and warrant further studies.

Key words: Factor V Leiden, G6PD, Silent mutation 1311, Dalmatia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0188-4409(04)00105-5

doi:10.1016/j.arcmed.2004.07.005

Archives of Medical Research
Volume 35, Issue 6 , Pages 546-548, November 2004